skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Refined by: resource type: Web Resources remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial
Material Type:
Web Resources
Add to My Research

Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial

European Respiratory Journal, 2021, Vol.57 (1), p.2003725 [Peer Reviewed Journal]

Copyright ©ERS 2020. ;2020. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright ©ERS 2021 2021 ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.03725-2020 ;PMID: 33361100

Digital Resources/Online E-Resources

2
Diffusion Capacity Abnormalities for Carbon Monoxide in Patients with COVID-19 At Three-Month Follow-up
Material Type:
Web Resources
Add to My Research

Diffusion Capacity Abnormalities for Carbon Monoxide in Patients with COVID-19 At Three-Month Follow-up

European Respiratory Journal, 2021, Vol.57 (2) [Peer Reviewed Journal]

Copyright ©ERS 2021. ;2021. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.03677-2020 ;PMID: 33574077

Digital Resources/Online E-Resources

3
Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory–confirmed COVID-19 cases
Material Type:
Web Resources
Add to My Research

Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory–confirmed COVID-19 cases

European Respiratory Journal, 2020, Vol.56 (1) [Peer Reviewed Journal]

2020. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1183/13993003.02144-2020

Digital Resources/Online E-Resources

4
Effect of asthma and asthma medication on the prognosis of patients with COVID-19
Material Type:
Web Resources
Add to My Research

Effect of asthma and asthma medication on the prognosis of patients with COVID-19

European Respiratory Journal, 2020, Vol.57 (3), p.2002226 [Peer Reviewed Journal]

Copyright ©ERS 2021. ;2020. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright ©ERS 2021 2021 ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.02226-2020 ;PMID: 32978309

Digital Resources/Online E-Resources

5
Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure
Material Type:
Web Resources
Add to My Research

Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure

European Respiratory Journal, 2020, Vol.57 (2), p.2002524 [Peer Reviewed Journal]

2020. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright ©ERS 2021 2021 ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.02524-2020 ;PMID: 33033151

Digital Resources/Online E-Resources

6
Stephan Achenbach, President of the ESC 2020-2022: Mark Nicholls speaks to Professor Stephan Achenbach as he prepares to take on the role of President of the European Society of Cardiology (ESC)
Material Type:
Web Resources
Add to My Research

Stephan Achenbach, President of the ESC 2020-2022: Mark Nicholls speaks to Professor Stephan Achenbach as he prepares to take on the role of President of the European Society of Cardiology (ESC)

European Heart Journal, 2020, Vol.41 (34), p.3210 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://academic.oup.com/journals/pages/coronavirus . ;DOI: 10.1093/eurheartj/ehaa718

Digital Resources/Online E-Resources

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To

Searching Remote Databases, Please Wait